Free Trial

JPMorgan Chase & Co. Boosts Stake in Xylem Inc. (NYSE:XYL)

Xylem logo with Business Services background

Key Points

  • JPMorgan Chase & Co. increased its stake in Xylem Inc. by 46.8% during the first quarter, owning 1,363,453 shares valued at approximately $162.9 million.
  • Xylem reported $1.26 EPS for the last quarter, exceeding estimates of $1.15, with a year-over-year revenue increase of 6.1%.
  • The company declared a quarterly dividend of $0.40 per share, representing an annualized yield of 1.1%.
  • Want stock alerts on Xylem? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

JPMorgan Chase & Co. lifted its holdings in Xylem Inc. (NYSE:XYL - Free Report) by 46.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,363,453 shares of the industrial products company's stock after buying an additional 434,614 shares during the period. JPMorgan Chase & Co. owned approximately 0.56% of Xylem worth $162,878,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of XYL. Northern Trust Corp increased its position in Xylem by 42.0% during the fourth quarter. Northern Trust Corp now owns 3,268,433 shares of the industrial products company's stock worth $379,204,000 after purchasing an additional 966,399 shares during the last quarter. OVERSEA CHINESE BANKING Corp Ltd increased its position in Xylem by 390.5% during the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company's stock worth $122,009,000 after purchasing an additional 813,100 shares during the last quarter. Vaughan Nelson Investment Management L.P. acquired a new stake in Xylem during the first quarter worth about $89,828,000. Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Xylem during the fourth quarter worth about $83,139,000. Finally, GAMMA Investing LLC increased its position in Xylem by 15,322.5% during the first quarter. GAMMA Investing LLC now owns 506,630 shares of the industrial products company's stock worth $60,522,000 after purchasing an additional 503,345 shares during the last quarter. 87.96% of the stock is currently owned by institutional investors and hedge funds.

Xylem Trading Down 1.2%

Shares of XYL stock opened at $141.87 on Friday. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $145.33. The company has a 50 day moving average price of $132.54 and a 200 day moving average price of $125.70. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.90. The stock has a market capitalization of $34.53 billion, a P/E ratio of 36.85, a price-to-earnings-growth ratio of 2.49 and a beta of 1.11.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The company had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. During the same quarter in the previous year, the firm earned $1.09 earnings per share. The firm's quarterly revenue was up 6.1% on a year-over-year basis. Equities research analysts predict that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 25th. Investors of record on Thursday, August 28th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem's dividend payout ratio is currently 41.56%.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the stock. Royal Bank Of Canada raised their price objective on shares of Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 30th. Raymond James Financial upgraded shares of Xylem to a "hold" rating in a research report on Thursday, May 15th. UBS Group lifted their price target on shares of Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a research report on Tuesday, August 5th. JPMorgan Chase & Co. began coverage on shares of Xylem in a research report on Friday, May 30th. They set an "overweight" rating and a $148.00 price target for the company. Finally, Citigroup reiterated a "buy" rating and set a $152.00 price target (up from $137.00) on shares of Xylem in a research report on Monday, July 14th. Three research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $151.57.

Get Our Latest Stock Report on XYL

About Xylem

(Free Report)

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.

Featured Stories

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Xylem Right Now?

Before you consider Xylem, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.

While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines